Skip to main content

Posts

Showing posts with the label Ephedrine

Bronchophane Syrup: A Historical Review of an Outdated Cough Formula

1. Disclaimer The information provided in this report is intended solely for educational and professional reference purposes and is not a substitute for medical advice, diagnosis, or treatment. Clinical decisions must always be based on the official prescribing information approved by regulatory authorities and the judgment of qualified healthcare professionals. We do not guarantee the accuracy, currency or completeness of information regarding medications or medical products, and official sources should be verified before making any decisions. By using this blog, you agree to assume personal responsibility for relying on the information provided. ⚠️ Critical Contextual Note: The primary source document for BRONCHOPHANE® Syrup (EIPICO leaflet, revision June 2011) is significantly outdated and reflects older polypharmacy practices that are no longer aligned with modern international guidelines, particularly due to the inclusion of ephedrine. Thi...

Bronchalin

Disclaimer: This information is for educational purposes and is not a substitute for professional medical advice. Bronchaline is a potent combination medication with a narrow therapeutic window and significant side effects. It should only be used under the strict supervision of a doctor. Bronchaline: A Guide to the Combination Asthma Medication Manufacturer: CID (Chemical Industries Development), Giza, Egypt Category: Combination Anti-Asthmatic (Bronchodilator, Decongestant, Antihistamine) Active Ingredients (per tablet): Theophylline anhydrous: 120 mg Ephedrine hydrochloride: 15 mg Hydroxyzine hydrochloride: 10 mg Available Form: Box of 20 tablets. Summary Bronchaline is a combination oral medication used in the management of bronchial asthma. It contains three active ingredients designed to work together to relax the airways, reduce congestion, and manage allergic and anxiety components of an asthma attack. It is important to note that while...